- Home
- NUWE vs BSX Comparison
NUWE vs BSX Comparison
Compare NUWE & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUWE | BSX |
|---|---|---|
| Founded | 1999 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 137.8B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | NUWE | BSX |
|---|---|---|
| Price | $2.05 | $96.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $125.88 |
| AVG Volume (30 Days) | 46.1K | ★ 10.5M |
| Earning Date | 11-12-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.68 |
| EPS | N/A | ★ 1.87 |
| Revenue | $8,167,999.00 | ★ $19,349,000,000.00 |
| Revenue This Year | N/A | $21.05 |
| Revenue Next Year | $10.48 | $11.43 |
| P/E Ratio | ★ N/A | $51.57 |
| Revenue Growth | N/A | ★ 21.61 |
| 52 Week Low | $2.02 | $85.98 |
| 52 Week High | $70.14 | $109.50 |
Technical Indicators
Market Signals| Indicator | NUWE | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 39.21 | 48.02 |
| Support Level | $2.13 | $95.20 |
| Resistance Level | $2.35 | $97.27 |
| Average True Range (ATR) | 0.19 | 2.09 |
| MACD | -0.01 | 0.32 |
| Stochastic Oscillator | 5.95 | 62.86 |
Price Performance
Historical ComparisonAbout NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.